CeroFlo is a medical device company developing a novel stent system designed to restore critical blood flow to the brain and prevent stroke. Intracranial atherosclerotic disease (ICAD) affects millions of patients worldwide yet remains drastically underserved by current treatment options.

Our approach eliminates key procedural complexities that have held back existing solutions, offering clinicians a safer and more scalable path to intervention. CeroFlo is led by a team of experienced neurovascular engineers and clinicians, and we are advancing toward first-in-human studies.